当前位置：
＞＞＞23，33和43分别可以按如下方式分裂成2个、3个和4个连续奇数的和，..
23，33和43分别可以按如下方式分裂成2个、3个和4个连续奇数的和，23=3+5，33=7+9+11，43=13+15+17+19，63也能按此规律进行分裂，则63分裂出的奇数中最大的是（　　）A．41B．39C．31D．29
题型：单选题难度：中档来源：不详
由23=3+5，分裂中的第一个数是：3=2×1+1，33=7+9+11，分裂中的第一个数是：7=3×2+1，43=13+15+17+19，分裂中的第一个数是：13=4×3+1，53=21+23+25+27+29，分裂中的第一个数是：21=5×4+1，63=31+33+35+37+39+41，分裂中的第一个数是：31=6×5+1，所以63“分裂”出的奇数中最大的是6×5+1+2×（6-1）=41．故选A．
马上分享给同学
据魔方格专家权威分析，试题“23，33和43分别可以按如下方式分裂成2个、3个和4个连续奇数的和，..”主要考查你对&&有理数定义及分类&&等考点的理解。关于这些考点的“档案”如下：
现在没空？点击收藏，以后再看。
因为篇幅有限，只列出部分考点，详细请访问。
有理数定义及分类
有理数的定义：有理数是整数和分数的统称，一切有理数都可以化成分数的形式。有理数的分类：（1）按有理数的定义：&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&正整数&&&&&&&&&&&&&&&&& 整数{&&&& 零&&&&&&&&&&&&&&&&&&&&&&&&&&&&& &负整数 有理数{&&&&& &&&&&&&&&&&&&&&&&&&&&&&& && 正分数&&&&&&&&&&&&&&&&&分数{ &&&&&&&&&&&&&&&&&&&&&&&&&&& 负分数 &（2）按有理数的性质分类:&&&&&&&&&&&&&&&&&&&&&&&&&&&&正整数&&&&&&&&&&&&&&&& 正数{&&&&&&&&&&&&&&&&&&&&&&&&&&&&正分数 有理数{& 零&&&&&&&&&&&&&&&&&&&&&&&&&&&负整数&&&&&&&&&&&&&&&&负数{ &&&&&&&&&&&&&&&&&&&&&&&&& &负分数
发现相似题
与“23，33和43分别可以按如下方式分裂成2个、3个和4个连续奇数的和，..”考查相似的试题有：
715510712809668041368180704990686793Other Product
9,35,39,46,48,49,50,52-Octaoxaoctacyclo[40.3.1.11,5.17,10.114,18.118,22.128,32.134,38]dopentaconta-6,23-diene-12,40-dione,44-(acetyloxy)-36-[(4S,5E)-7-chloro-4-hydroxy-2-methylene-5,7-octadienyl]-3,20,30,32,33,37-hexahydroxy-16-methoxy-3,11,29,47,51-pentamethyl-,(1R,3S,5R,6E,10S,11S,14S,16S,18S,20S,22R,23Z,28R,29R,30S,32R,33S,34R,36R,37R,38R,42R,44S,47S,51R)-(9CI)
9,35,39,46,48,49,50,52-Octaoxaoctacyclo[40.3.1.11,5.17,10.114,18.118,22.128,32.134,38]dopentaconta-6,23-diene-12,40-dione,44-(acetyloxy)-3,20,30,32,33,37-hexahydroxy-36-[(4S,5E)-4-hydroxy-2-methylene-5,7-octadienyl]-16-methoxy-3,11,29,47,51-pentamethyl-,(1R,3S,5R,6E,10S,11S,14S,16S,18S,20S,22R,23Z,28R,29R,30S,32R,33S,34R,36R,37R,38R,42R,44S,47S,51R)-(9CI)
1/C51H74N2/c1-5-9-13-17-21-49(22-18-14-10-6-2)42-53(43-50(23-19-15-11-7-3)24-20-16-12-8-4)51-39-37-47(38-40-51)32-31-45-27-25-44(26-28-45)29-30-46-33-35-48(41-52)36-34-46/h25-40,49-50H,5-24,42-43H2,1-4H3/b30-29+,32-31
1/C28H41N5O15S.Na/c1-12(2)21(28(42)43)33-26(41)17(9-15-5-7-16(8-6-15)48-49(44,45)46)31-25(40)18(29-13(3)35)10-20(37)32-27-22(30-14(4)36)24(39)23(38)19(11-34)47-27;/h5-8,12,17-19,21-24,27,34,38-39H,9-11H2,1-4H3,(H,29,35)(H,30,36)(H,31,40)(H,32,37)(H,33,41
1/C33H42O7/c1-19-25-17-24-18-27(39-22(4)35)20(2)29(32(24,5)6)30(37)31(33(25,7)16-15-26(19)38-21(3)34)40-28(36)14-13-23-11-9-8-10-12-23/h8-14,24-27,30-31,37H,1,15-18H2,2-7H3/b14-13+/t24-,25-,26+,27+,30-,31+,33-/m1/s
8,12,45,46,47,48,50-Heptaoxaheptacyclo[39.3.1.11,5.19,13.115,19.125,29.129,33]pentacont-23-ene-7,35-dione,3,37-bis(acetyloxy)-11-[(4S,5E)-7-chloro-4-hydroxy-2-methylene-5,7-octadienyl]-10,14,15,17,27,43-hexahydroxy-31-methoxy-18,36,38,43,49-pentamethyl-39-methylene-,(1S,3S,5R,9R,10R,11R,13R,14S,15R,17S,18R,19R,23Z,25R,27S,29S,31S,33S,36S,37S,38R,41S,43S,49S)-
(5E)-5-[(3aS,4R,5R,6aS)-4-[(1E,3S)-3-cyclopentyl-3-hydroxyprop-1-en-1-yl]-5-hydroxyhexahydropentalen-2(1H)-ylidene]pentanoic acid - (1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31R,32R,33R,34R,35R,36R,37R,38R,39R,40R,41R,42R)-5,10,1
11',29'-di-tert-butyl-5',17',23',35',38',40',43',45'-octamethyl-7',15',25',33'-tetraoxadispiro[cyclohexane-1,2'-heptacyclo[32.2.2.2~3,6~.2~16,19~.2~21,24~.1~9,13~.1~27,31~]hexatetracontane-20',1''-cyclohexane]-1'(36'),3',5',9'(44'),10',12',16',18',21',23'
8,12,45,46,47,48,50-Heptaoxaheptacyclo[39.3.1.11,5.19,13.115,19.125,29.129,33]pentacont-23-ene-7,35-dione,3,37-bis(acetyloxy)-10,14,15,17,27,43-hexahydroxy-11-[(4S,5E)-4-hydroxy-2-methylene-5,7-octadien-1-yl]-31-methoxy-18,36,38,43,49-pentamethyl-39-methylene-,(1S,3S,5R,9R,10R,11R,13R,14S,15R,17S,18R,19R,23Z,25R,27S,29S,31S,33S,36S,37S,38R,41S,43S,49S)-
(2R,3S,4S,5R,8R,10R,11S,12S,15R,17R,18S,19S,22R,24R,25S,26S,29R,31R,32S,33S,36R,38R,39S,40S)-2,10,17,24,31,38-hexakis(hydroxymethyl)-1,6,9,13,16,20,23,27,30,34,37,41-dodecaoxahexaspiro[4.2.4~8~.2.4~15~.2.4~22~.2.4~29~.2.4~36~.2~5~]dotetracontane-3,4,11,12
9,35,39,46,48,49,50,52-Octaoxaoctacyclo[40.3.1.11,5.17,10.114,18.118,22.128,32.134,38]dopentaconta-6,23-diene-12,40-dione,36-[(4S,5E)-7-chloro-4-hydroxy-2-methylene-5,7-octadienyl]-3,20,30,32,33,37,44-heptahydroxy-16-methoxy-3,11,29,47,51-pentamethyl-,(1R,3S,5R,6E,10S,11S,14S,16S,18S,20S,22R,23Z,28R,29R,30S,32R,33S,34R,36R,37R,38R,42R,44S,47S,51R)-(9CI) (Molecular Formula: C59H89 Cl O19)
Product Name:
9,35,39,46,48,49,50,52-Octaoxaoctacyclo[40.3.1.11,5.17,10.114,18.118,22.128,32.134,38]dopentaconta-6,23-diene-12,40-dione,36-[(4S,5E)-7-chloro-4-hydroxy-2-methylene-5,7-octadienyl]-3,20,30,32,33,37,44-heptahydroxy-16-methoxy-3,11,29,47,51-pentamethyl-,(1R,3S,5R,6E,10S,11S,14S,16S,18S,20S,22R,23Z,28R,29R,30S,32R,33S,34R,36R,37R,38R,42R,44S,47S,51R)-(9CI)
CAS Registry Number:
9,35,39,46,48,49,50,52-Octaoxaoctacyclo[40.3.1.11,5.17,10.114,18.118,22.128,32.134,38]dopentaconta-6,23-diene-12,40-dione,36-(7-chloro-4-hydroxy-2-methylene-5,7-octadienyl)-3,20,30,32,33,37,44-heptahydroxy-16-methoxy-3,11,29,47,51-pentamethyl-,[1R-[1R*,3S*,5R*,6E,10S*,11S*,14S*,16S*,18S*,20S*,22R*,23Z,28R*,29R*,30S*,32R*,33S*,34R*,36R*(4S*,5E),37R*,38R*,42R*,44S*,47S*,51R*]]-;Spongiostatin 5; Spongistatin 5
Molecular Structure:
Molecular Formula:
C59H89 Cl O19}